After adjusting for well known prognostic factors in multivariate analysis, de Jong and colleagues [24] found that the presence of high numbers of CD8+ TILs was an independent predictor of increased OS (whole cohort and type II) and that the presence of a high CD8+/FoxP3+ ratio was an independent predictor of increased disease-free survival (DFS) in type I, though not type II, endometrial cancer patients. Here, CD8A is linked to endometrial cancer.